The latest installment in BioPharma Dive’s visualization-focused series features a look at investors’ response to a trio of ...

The occurrence of cancer in nine recipients — two of which involved evidence that a viral delivery tool integrated into ...

Today, a brief rundown of news involving Eli Lilly and Alnylam Pharmaceuticals, as well as updates from Servier, Ultragenyx, Boehringer Ingelheim and ANI Pharmaceuticals that you may have missed.